{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T01:36:25Z","timestamp":1792028185561,"version":"4.4.0"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T00:00:00Z","timestamp":1616457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T00:00:00Z","timestamp":1616457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Fondazione of the Italian Society of Hypertension","award":["MIOL"],"award-info":[{"award-number":["MIOL"]}]},{"DOI":"10.13039\/501100004702","name":"Universit\u00e0 degli Studi di Genova","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004702","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hyperuricemia is commonly observed in patients with chronic kidney disease (CKD). However, a better understanding of the relationship among uric acid (UA) values, glomerular filtration rate (GFR) and albuminuria may shed light on the mechanisms underlying the excess of cardiovascular mortality associated with both chronic kidney disease and hyperuricemia and lead to better risk stratification. Our main goal was to study the relationships between serum uric acid and kidney disease measures (namely estimated GFR [eGFR] and albuminuria) in a large cohort of individuals at cardiovascular risk from the URic acid Right for heArt Health (URRAH) Project database.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Clinical data of 26,971 individuals were analyzed. Factors associated with the presence of hyperuricemia defined on the basis of previously determined URRAH cutoffs for cardiovascular and all-cause mortality were evaluated through multivariate analysis. Chronic kidney disease was defined as eGFR\u2009&lt;\u200960\u00a0ml\/min per 1.73 m\n                      <jats:sup>2<\/jats:sup>\n                      and\/or abnormal urinary albumin excretion diagnosed as: (i) microalbuminuria if urinary albumin concentration was\u2009&gt;\u200930 and\u2009\u2264\u2009300\u00a0mg\/L, or if urinary albumin-to-creatinine ratio (ACR) was\u2009&gt;\u20093.4\u00a0mg\/mmol and\u2009\u2264\u200934\u00a0mg\/mmol; (ii) macroalbuminuria if urinary albumin concentration was\u2009&gt;\u2009300\u00a0mg\/L, or if ACR was\u2009&gt;\u200934\u00a0mg\/mmol.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Mean age was 58\u2009\u00b1\u200915\u00a0years (51% males, 62% with hypertension and 12% with diabetes), mean eGFR was 81\u00a0ml\/min per 1.73m2\n                      <jats:sup>2<\/jats:sup>\n                      with a prevalence of eGFR\u2009&lt;\u200960 and micro- or macroalbuminuria of 16, 15 and 4%, respectively. Serum uric acid showed a trend towards higher values along with decreasing renal function. Both the prevalence of gout and the frequency of allopurinol use increased significantly with the reduction of eGFR and the increase in albuminuria. Hyperuricemia was independently related to male gender, eGFR strata, and signs of insulin resistance such as body mass index (BMI) and triglycerides.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The lower the eGFR the higher the prevalence of hyperuricemia and gout. In subjects with eGFR\u2009&lt;\u200960\u00a0ml\/min the occurrence of hyperuricemia is about 10 times higher than in those with eGFR\u2009&gt;\u200990\u00a0ml\/min. The percentage of individuals treated with allopurinol was below 2% when GFR was above 60\u00a0ml\/min, it increased to 20% in the presence of CKD 3b and rose further to 35% in individuals with macroalbuminuria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphic abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1007\/s40620-021-00985-4","type":"journal-article","created":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T07:03:47Z","timestamp":1616483027000},"page":"211-221","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Association of uric acid with kidney function and albuminuria: the Uric Acid Right for heArt Health (URRAH) Project"],"prefix":"10.1093","volume":"35","author":[{"given":"Elisa","family":"Russo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4219-7043","authenticated-orcid":false,"given":"Francesca","family":"Viazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Pontremoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo Maria","family":"Barbagallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Bombelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Casiglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arrigo Francesco Giuseppe","family":"Cicero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Cirillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Cirillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovambattista","family":"Desideri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanfranco","family":"D\u2019Elia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Ferri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferruccio","family":"Galletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loreto","family":"Gesualdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Giannattasio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Iaccarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Leoncini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Mallamaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Maloberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Masi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Mengozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Mazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Lorenza","family":"Muiesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Nazzaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Palatini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Parati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Rattazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Rivasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Salvetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Tikhonoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliano","family":"Tocci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Ungar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Verdecchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agostino","family":"Virdis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Volpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Grassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Borghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the Working Group on UricAcid and Cardiovascular Risk of the Italian Society of Hypertension","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,3,23]]},"reference":[{"issue":"17","key":"985_CR1","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1056\/NEJMra0800885","volume":"359","author":"DI Feig","year":"2008","unstructured":"Feig DI, Kang DH, Johnson RJ (2008) Uric acid and cardiovascular risk. N Engl J Med. 359(17):1811\u20131821. https:\/\/doi.org\/10.1056\/NEJMra0800885","journal-title":"N Engl J Med."},{"issue":"2","key":"985_CR2","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1161\/HYPERTENSIONAHA.119.13643","volume":"75","author":"A Virdis","year":"2020","unstructured":"Virdis A, Masi S, Casiglia E et al (2020) From the Working Group on Uric Acid and Cardiovascular Risk of the Italian Society of Hypertension. Identification of the uric acid thresholds predicting an increased total and cardiovascular mortality over 20 years. Hypertension 75(2):302\u2013308. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.119.13643","journal-title":"Hypertension"},{"issue":"4","key":"985_CR3","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s40620-020-00702-7","volume":"33","author":"B Bonino","year":"2020","unstructured":"Bonino B, Leoncini G, Russo E, Pontremoli R, Viazzi F (2020) Uric acid in CKD: has the jury come to the verdict? J Nephrol 33(4):715\u2013724. https:\/\/doi.org\/10.1007\/s40620-020-00702-7 (Epub 2020 Jan 13 PMID: 31933161)","journal-title":"J Nephrol"},{"issue":"8","key":"985_CR4","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.numecd.2014.01.018","volume":"24","author":"F Viazzi","year":"2014","unstructured":"Viazzi F, Garneri D, Leoncini G et al (2014) Serum uric acid and its relationship with metabolic syndrome and cardiovascular risk profile in patients with hypertension: insights from the I-DEMAND study. Nutr Metab Cardiovasc Dis 24(8):921\u2013927. https:\/\/doi.org\/10.1016\/j.numecd.2014.01.018 (Epub 2014 Feb 8 PMID: 24675005)","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"985_CR5","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1053\/j.ajkd.2008.12.021","volume":"53","author":"M Madero","year":"2009","unstructured":"Madero M, Sarnak MJ, Wang X, Greene T, Beck GJ, Kusek JW, Collins AJ, Levey AS, Menon V (2009) Uric acid and long-term outcomes in CKD. Am J Kidney Dis 53:796\u2013803","journal-title":"Am J Kidney Dis"},{"key":"985_CR6","doi-asserted-by":"publisher","first-page":"e0118031","DOI":"10.1371\/journal.pone.0118031","volume":"10","author":"E Kanda","year":"2015","unstructured":"Kanda E, Muneyuki T, Kanno Y, Suwa K, Nakajima K (2015) Uric acid level has a U-shaped association with loss of kidney function in healthy people: a prospective cohort study. PLoS ONE 10:e0118031","journal-title":"PLoS ONE"},{"key":"985_CR7","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1159\/000484284","volume":"192","author":"M Mauer","year":"2018","unstructured":"Mauer M, Doria A (2018) Uric acid and diabetic nephropathy risk. Contrib Nephrol 192:103\u2013109","journal-title":"Contrib Nephrol"},{"issue":"2","key":"985_CR8","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1053\/j.ajkd.2007.05.013","volume":"50","author":"M Chonchol","year":"2007","unstructured":"Chonchol M, Shlipak MG, Katz R et al (2007) Relationship of uric acid with progression of kidney disease. Am J Kidney Dis 50(2):239\u2013247. https:\/\/doi.org\/10.1053\/j.ajkd.2007.05.013 (PMID: 17660025)","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"985_CR9","doi-asserted-by":"publisher","first-page":"e100801","DOI":"10.1371\/journal.pone.0100801","volume":"9","author":"P Zhu","year":"2014","unstructured":"Zhu P, Liu Y, Han L, Xu G, Ran JM (2014) Serum uric acid is associated with incident chronic kidney disease in middle-aged populations: a meta-analysis of 15 cohort studies. PLoS ONE 9(6):e100801. https:\/\/doi.org\/10.1371\/journal.pone.0100801","journal-title":"PLoS ONE"},{"issue":"11","key":"985_CR10","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.2215\/CJN.03140315","volume":"10","author":"S De Cosmo","year":"2015","unstructured":"De Cosmo S, Viazzi F, Pacilli A et al (2015) Serum Uric Acid and Risk of CKD in Type 2 Diabetes. Clin J Am Soc Nephrol 10(11):1921\u20131929. https:\/\/doi.org\/10.2215\/CJN.03140315","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"985_CR11","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/S2213-8587(15)00040-6","volume":"3","author":"K Matsushita","year":"2015","unstructured":"Matsushita K, Coresh J, Sang Y et al (2015) Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data. Lancet Diabetes Endocrinol 3(7):514\u2013525. https:\/\/doi.org\/10.1016\/S2213-8587(15)00040-6","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"985_CR12","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1002\/art.10792","volume":"47","author":"F Perez-Ruiz","year":"2002","unstructured":"Perez-Ruiz F, Calabozo M, Erauskin GG, Ruibal A, Renalunder H-B (2002) Excretion of uric acid is present in patients with apparent high urinary uric acid output. Arthritis Rheum 47(6):610\u2013613","journal-title":"Arthritis Rheum"},{"issue":"4","key":"985_CR13","doi-asserted-by":"publisher","first-page":"R189","DOI":"10.1186\/ar4020","volume":"14","author":"DR Kannangara","year":"2012","unstructured":"Kannangara DR, Ramasamy SN, Indraratna PL et al (2012) Fractional clearance of urate: validation ofmeasurement in spot-urine samples in healthy subjects and gouty patients. Arthritis Res Ther 14(4):R189","journal-title":"Arthritis Res Ther"},{"key":"985_CR14","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/sj.ki.5001641","volume":"70","author":"M Cirillo","year":"2006","unstructured":"Cirillo M, Laurenzi M, Mancini M, Zanchetti A, Lombardi C, De Santo NG (2006) Low glomerular filtration in the population: prevalence, associated disorders, and awareness. Kidney Int 70:800\u2013806. https:\/\/doi.org\/10.1038\/sj.ki.5001641","journal-title":"Kidney Int"},{"issue":"2","key":"985_CR15","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s40292-018-0250-7","volume":"25","author":"Desideri G, Virdis A, Casiglia E, Borghi C; Working Group on Uric Acid and Cardiovascular Risk of the Italian Society of Hypertension","year":"2018","unstructured":"Desideri G, Virdis A, Casiglia E, Borghi C; Working Group on Uric Acid and Cardiovascular Risk of the Italian Society of Hypertension (2018) Exploration into Uric and Cardiovascular Disease: Uric Acid Right for heArt Health (URRAH) Project, A Study Protocol for a Retrospective Observational Study. High Blood Press Cardiovasc Prev 25(2):197\u2013202. https:\/\/doi.org\/10.1007\/s40292-018-0250-7","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"985_CR16","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI et al (2009) CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604\u2013612","journal-title":"Ann Intern Med"},{"issue":"2","key":"985_CR17","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s11926-012-0240-z","volume":"14","author":"MS Lipkowitz","year":"2012","unstructured":"Lipkowitz MS (2012) Regulation of uric acid excretion by the kidney. Curr Rheumatol Rep 14(2):179\u2013188","journal-title":"Curr Rheumatol Rep"},{"issue":"11","key":"985_CR18","doi-asserted-by":"publisher","first-page":"e50046","DOI":"10.1371\/journal.pone.0050046","volume":"7","author":"E Krishnan","year":"2012","unstructured":"Krishnan E (2012) Reduced glomerular function and prevalence of gout: NHANES 2009\u201310. PLoS ONE 7(11):e50046. https:\/\/doi.org\/10.1371\/journal.pone.0050046","journal-title":"PLoS ONE"},{"issue":"10","key":"985_CR19","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1089\/met.2017.0025","volume":"15","author":"ND Madala","year":"2017","unstructured":"Madala ND, Dubula T, Assounga AGH, Naicker S (2017) Association of Kidney Function and Waist Circumference with Uric Acid Levels in South Africans. Metab Syndr Relat Disord 15(10):500\u2013506. https:\/\/doi.org\/10.1089\/met.2017.0025 (Epub 2017 Nov 20 PMID: 29154722)","journal-title":"Metab Syndr Relat Disord"},{"issue":"4","key":"985_CR20","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1093\/ndt\/gfu352","volume":"30","author":"J Jing","year":"2015","unstructured":"Jing J, Kielstein JT, Schultheiss UT et al (2015) Prevalence and correlates of gout in a large cohort of patients with chronic kidney disease: the German Chronic Kidney Disease (GCKD) study. Nephrol Dial Transplant 30(4):613\u2013621. https:\/\/doi.org\/10.1093\/ndt\/gfu352 (Epub 2014 Nov 13 PMID: 25395390)","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"985_CR21","doi-asserted-by":"publisher","first-page":"577","DOI":"10.2215\/CJN.06790616","volume":"12","author":"VS Tan","year":"2017","unstructured":"Tan VS, Garg AX, McArthur E, Lam NN, Sood MM, Naylor KL (2017) The 3-year incidence of gout in elderly patients with CKD. Clin J Am Soc Nephrol. 12(4):577\u2013584. https:\/\/doi.org\/10.2215\/CJN.06790616 (Epub 2017 Feb 2. PMID: 28153936; PMCID: PMC5383383)","journal-title":"Clin J Am Soc Nephrol."},{"issue":"6","key":"985_CR22","doi-asserted-by":"publisher","first-page":"e0129797","DOI":"10.1371\/journal.pone.0129797","volume":"10","author":"D Yan","year":"2015","unstructured":"Yan D, Tu Y, Jiang F et al (2015) Uric Acid is independently associated with diabetic kidney disease: a cross-sectional study in a Chinese population. PLoS ONE 10(6):e0129797. https:\/\/doi.org\/10.1371\/journal.pone.0129797 (PMID: 26029914; PMCID: PMC4451151)","journal-title":"PLoS ONE"},{"issue":"9","key":"985_CR23","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1007\/s00125-015-3650-4.PMID:26049401;PMCID:PMC4826347","volume":"58","author":"P Bjornstad","year":"2015","unstructured":"Bjornstad P, Lanaspa MA, Ishimoto T et al (2015) Fructose and uric acid in diabetic nephropathy. Diabetologia 58(9):1993\u20132002. https:\/\/doi.org\/10.1007\/s00125-015-3650-4.PMID:26049401;PMCID:PMC4826347","journal-title":"Diabetologia"},{"issue":"1","key":"985_CR24","doi-asserted-by":"publisher","first-page":"F173","DOI":"10.1152\/ajprenal.00462.2018","volume":"316","author":"A Novikov","year":"2019","unstructured":"Novikov A, Fu Y, Wet H et al (2019) SGLT2 inhibition and renal urate excretion: role of luminal glucose, GLUT9, and URAT1. Am J Physiol Renal Physiol. 316(1):F173\u2013F185. https:\/\/doi.org\/10.1152\/ajprenal.00462.2018 (PMID: 30427222; PMCID: PMC6383194)","journal-title":"Am J Physiol Renal Physiol."},{"issue":"1","key":"985_CR25","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12882-018-0892-7","volume":"19","author":"F Li","year":"2018","unstructured":"Li F, Guo H, Zou J, Chen W, Lu Y, Zhang X et al (2018) Urinary excretion of uric acid is negatively associated with albuminuria in patients with chronic kidney disease: a cross-sectional study. BMC Nephrol 19(1):95. https:\/\/doi.org\/10.1186\/s12882-018-0892-7 (PMID:29699501;PMCID:PMC5922015)","journal-title":"BMC Nephrol"},{"key":"985_CR26","doi-asserted-by":"publisher","first-page":"e0170393","DOI":"10.1371\/journal.pone.0170393","volume":"12","author":"CW Tsai","year":"2017","unstructured":"Tsai CW, Lin SY, Kuo CC, Huang CC (2017) Serum uric acid and progression of kidney disease: a longitudinal analysis and mini-review. PLoS ONE 12:e0170393","journal-title":"PLoS ONE"},{"issue":"26","key":"985_CR27","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1056\/NEJMoa1916624","volume":"382","author":"A Doria","year":"2020","unstructured":"Doria A, Galecki AT, Spino C et al (2020) Serum urate lowering with allopurinol and kidney function in type 1 diabetes. N Engl J Med 382(26):2493\u20132503. https:\/\/doi.org\/10.1056\/NEJMoa1916624 (PMID: 32579810)","journal-title":"N Engl J Med"},{"issue":"26","key":"985_CR28","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1056\/NEJMoa1915833","volume":"382","author":"SV Badve","year":"2020","unstructured":"Badve SV, Pascoe EM, Tiku A et al (2020) Effects of allopurinol on the progression of chronic kidney disease. N Engl J Med 382(26):2504\u20132513. https:\/\/doi.org\/10.1056\/NEJMoa1915833 (PMID: 32579811)","journal-title":"N Engl J Med"},{"issue":"1","key":"985_CR29","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1053\/j.ajkd.2005.10.006","volume":"47","author":"YP Siu","year":"2006","unstructured":"Siu YP, Leung KT, Tong MLK, Kwan TH (2006) Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am J Kidney Dis 47(1):51\u201359","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"985_CR30","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.2215\/CJN.01580210","volume":"5","author":"M Goicoechea","year":"2010","unstructured":"Goicoechea M, de Vinuesa SG, Verdalles U et al (2010) Effect of allopurinol in chronic kidney disease progression and cardiovascular risk. Clin J Am Soc Nephrol 5(8):1388\u20131393","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"985_CR31","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1053\/j.ajkd.2014.11.016","volume":"65","author":"M Goicoechea","year":"2015","unstructured":"Goicoechea M, Garcia de Vinuesa S, Verdalles U et al (2015) Allopurinol and progression of CKD and cardiovascular events: long-term follow-up of a randomized clinical trial. Am J Kidney Dis 65(4):543\u2013549","journal-title":"Am J Kidney Dis"},{"issue":"22","key":"985_CR32","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1093\/eurheartj\/ehz119.PMID:30844048;PMCID:PMC6554652","volume":"40","author":"S Kojima","year":"2019","unstructured":"Kojima S, Matsui K, Hiramitsu S et al (2019) Febuxostat for cerebral and CaRdiorenovascular Events PrEvEntion StuDy. Eur Heart J 40(22):1778\u20131786. https:\/\/doi.org\/10.1093\/eurheartj\/ehz119.PMID:30844048;PMCID:PMC6554652","journal-title":"Eur Heart J"},{"issue":"6","key":"985_CR33","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1053\/j.ajkd.2018.06.028","volume":"72","author":"K Kimura","year":"2018","unstructured":"Kimura K, Hosoya T, Uchida S et al (2018) Febuxostat therapy for patients with stage 3 CKD and asymptomatic hyperuricemia: a randomized trial. Am J Kidney Dis 72(6):798\u2013810. https:\/\/doi.org\/10.1053\/j.ajkd.2018.06.028 (Epub 2018 Sep 1 PMID: 30177485)","journal-title":"Am J Kidney Dis"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-021-00985-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-021-00985-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-021-00985-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:58:55Z","timestamp":1777564735000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/35\/1\/211\/8439636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,23]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["985"],"URL":"https:\/\/doi.org\/10.1007\/s40620-021-00985-4","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,23]]},"assertion":[{"value":"6 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"There are no relevant conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This work has been conducted with an unrestricted grant from the Fondazione of the Italian Society of Hypertension (grant: MIOL).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Support"}},{"value":"All procedures performed in the study involving human participants were in accordance with the ethical standards of the Trust and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of study formal consent is not required.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}